Fernandez Salamanca, Mar
van Houdt, Petra J.
Hompland, Tord
Deręgowska-Cylke, Malgorzata
van Leeuwen, Pim J.
van der Poel, Henk G.
Bekers, Elise
Guimaraes, Marcos A.S.
Lyng, Heidi
van der Heide, Uulke A.
Schoots, Ivo G.
Funding for this research was provided by:
KWF Kankerbestrijding (12975)
Article History
Received: 9 April 2025
Accepted: 21 November 2025
First Online: 9 December 2025
Declarations
:
: The studies involving humans were approved by the Netherlands Cancer Institute - IRBd21-108. The study was conducted in accordance with the relevant local and institutional guidelines and/or regulations including the Declaration of Helsinki.
: The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants’ legal guardians/next of kin because pursuant to national legislation prior to 25 May 2018 (Opt-out) and General hospital informed consent was considered.
: The authors declare no competing interests.